Human Gene CD3G (ENST00000532917.3_6) from GENCODE V47lift37
  Description: CD3 gamma subunit of T-cell receptor complex (from RefSeq NM_000073.3)
Gencode Transcript: ENST00000532917.3_6
Gencode Gene: ENSG00000160654.11_9
Transcript (Including UTRs)
   Position: hg19 chr11:118,215,059-118,225,876 Size: 10,818 Total Exon Count: 7 Strand: +
Coding Region
   Position: hg19 chr11:118,215,139-118,223,184 Size: 8,046 Coding Exon Count: 6 

Page IndexSequence and LinksUniProtKB CommentsPrimersMalaCardsCTD
Gene AllelesRNA-Seq ExpressionMicroarray ExpressionRNA StructureProtein StructureOther Species
GO AnnotationsmRNA DescriptionsPathwaysOther NamesModel InformationMethods
Data last updated at UCSC: 2024-08-22 23:36:26

-  Sequence and Links to Tools and Databases
 
Genomic Sequence (chr11:118,215,059-118,225,876)mRNA (may differ from genome)Protein (182 aa)
Gene SorterGenome BrowserOther Species FASTAVisiGeneGene interactionsTable Schema
AlphaFoldBioGPSEnsemblEntrez GeneExonPrimerGeneCards
HGNCMalacardsMGIOMIMPubMedReactome
UniProtKBWikipediaBioGrid CRISPR DB

-  Comments and Description Text from UniProtKB
  ID: CD3G_HUMAN
DESCRIPTION: RecName: Full=T-cell surface glycoprotein CD3 gamma chain; AltName: Full=T-cell receptor T3 gamma chain; AltName: CD_antigen=CD3g; Flags: Precursor;
FUNCTION: The CD3 complex mediates signal transduction.
SUBUNIT: The TCR/CD3 complex of T-lymphocytes consists of either a TCR alpha/beta or TCR gamma/delta heterodimer coexpressed at the cell surface with the invariant subunits of CD3 labeled gamma, delta, epsilon, zeta, and eta.
SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane protein.
DOMAIN: A di-leucine motif and a tyrosine-based motif are individually sufficient to induce both endocytosis and delivery to lysosomes.
SIMILARITY: Contains 1 Ig-like (immunoglobulin-like) domain.
SIMILARITY: Contains 1 ITAM domain.
WEB RESOURCE: Name=CD3Gbase; Note=CD3G mutation db; URL="http://bioinf.uta.fi/CD3Gbase/";
WEB RESOURCE: Name=Wikipedia; Note=CD3 receptor entry; URL="http://en.wikipedia.org/wiki/CD3_receptor";

-  Primer design for this transcript
 

Primer3Plus can design qPCR Primers that straddle exon-exon-junctions, which amplify only cDNA, not genomic DNA.
Click here to load the transcript sequence and exon structure into Primer3Plus

Exonprimer can design one pair of Sanger sequencing primers around every exon, located in non-genic sequence.
Click here to open Exonprimer with this transcript

To design primers for a non-coding sequence, zoom to a region of interest and select from the drop-down menu: View > In External Tools > Primer3


-  MalaCards Disease Associations
  MalaCards Gene Search: CD3G
Diseases sorted by gene-association score: immunodeficiency 17, cd3 gamma deficient* (1250), immunodeficiency due to defect in cd3-gamma* (100), cd3gamma deficiency (18), enteropathy-associated t-cell lymphoma (13), cd3delta deficiency (12), immune defect due to absence of thymus (7), cd3epsilon deficiency (7), lymphopenia (6), t cell deficiency (6), evans' syndrome (5), combined t cell and b cell immunodeficiency (4)
* = Manually curated disease association

-  Comparative Toxicogenomics Database (CTD)
  The following chemicals interact with this gene           more ... click here to view the complete list

+  Common Gene Haplotype Alleles
  Press "+" in the title bar above to open this section.

-  RNA-Seq Expression Data from GTEx (53 Tissues, 570 Donors)
  Highest median expression: 4.41 RPKM in Spleen
Total median expression: 16.00 RPKM



View in GTEx track of Genome Browser    View at GTEx portal     View GTEx Body Map

+  Microarray Expression Data
  Press "+" in the title bar above to open this section.

-  mRNA Secondary Structure of 3' and 5' UTRs
 
RegionFold EnergyBasesEnergy/Base
Display As
5' UTR -26.0080-0.325 Picture PostScript Text
3' UTR -489.102061-0.237 Picture PostScript Text

The RNAfold program from the Vienna RNA Package is used to perform the secondary structure predictions and folding calculations. The estimated folding energy is in kcal/mol. The more negative the energy, the more secondary structure the RNA is likely to have.

-  Protein Domain and Structure Information
  InterPro Domains: Graphical view of domain structure
IPR015484 - CD3_gsu/dsu
IPR013783 - Ig-like_fold
IPR003598 - Ig_sub2
IPR003110 - Phos_immunorcpt_sig_ITAM

Pfam Domains:
PF02189 - Immunoreceptor tyrosine-based activation motif
PF16680 - T-cell surface glycoprotein CD3 delta chain
PF16681 - Ig-like domain on T-cell surface glycoprotein CD3 epsilon chain

SCOP Domains:
48726 - Immunoglobulin

Protein Data Bank (PDB) 3-D Structure
MuPIT help
1SY6 - X-ray MuPIT


ModBase Predicted Comparative 3D Structure on P09693
FrontTopSide
The pictures above may be empty if there is no ModBase structure for the protein. The ModBase structure frequently covers just a fragment of the protein. You may be asked to log onto ModBase the first time you click on the pictures. It is simplest after logging in to just click on the picture again to get to the specific info on that model.

-  Orthologous Genes in Other Species
  Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
MouseRatZebrafishD. melanogasterC. elegansS. cerevisiae
No orthologNo orthologNo orthologNo orthologNo orthologNo ortholog
Gene DetailsGene Details    
Gene SorterGene Sorter    
 RGD    
      
      

-  Gene Ontology (GO) Annotations with Structured Vocabulary
  Molecular Function:
GO:0004888 transmembrane signaling receptor activity
GO:0030159 receptor signaling complex scaffold activity
GO:0042608 T cell receptor binding
GO:0042803 protein homodimerization activity
GO:0046982 protein heterodimerization activity

Biological Process:
GO:0002250 adaptive immune response
GO:0002376 immune system process
GO:0007163 establishment or maintenance of cell polarity
GO:0007166 cell surface receptor signaling pathway
GO:0015031 protein transport
GO:0038096 Fc-gamma receptor signaling pathway involved in phagocytosis
GO:0042110 T cell activation
GO:0050776 regulation of immune response
GO:0050852 T cell receptor signaling pathway
GO:0051260 protein homooligomerization
GO:0061024 membrane organization
GO:0065003 macromolecular complex assembly
GO:0070228 regulation of lymphocyte apoptotic process

Cellular Component:
GO:0005886 plasma membrane
GO:0005887 integral component of plasma membrane
GO:0016020 membrane
GO:0016021 integral component of membrane
GO:0030665 clathrin-coated vesicle membrane
GO:0042101 T cell receptor complex
GO:0042105 alpha-beta T cell receptor complex


-  Descriptions from all associated GenBank mRNAs
  AK299997 - Homo sapiens cDNA FLJ51080 complete cds, moderately similar to T-cell surface glycoprotein CD3 gamma chain precursor.
AK313966 - Homo sapiens cDNA, FLJ94613, Homo sapiens CD3G antigen, gamma polypeptide (TiT3 complex) (CD3G),mRNA.
JD470112 - Sequence 451136 from Patent EP1572962.
AK315895 - Homo sapiens cDNA, FLJ79544 complete cds, highly similar to T-cell surface glycoprotein CD3 gamma chainprecursor.
AK310622 - Homo sapiens cDNA, FLJ17664.
X60492 - Human mRNA for CD3-gamma, with 17 bp deletion associated with T-cell receptor immunodeficiency.
BC069685 - Homo sapiens cDNA clone IMAGE:7262517, containing frame-shift errors.
X04145 - Human mRNA for T-cell receptor T3 gamma polypeptide.
AK223314 - Homo sapiens mRNA for CD3G gamma precursor variant, clone: TMS06008.
AK310578 - Homo sapiens cDNA, FLJ17620.
JD141202 - Sequence 122226 from Patent EP1572962.
BC113830 - Homo sapiens CD3g molecule, gamma (CD3-TCR complex), mRNA (cDNA clone MGC:138597 IMAGE:40029587), complete cds.
KJ890851 - Synthetic construct Homo sapiens clone ccsbBroadEn_00245 CD3G gene, encodes complete protein.
JD311122 - Sequence 292146 from Patent EP1572962.
JD147485 - Sequence 128509 from Patent EP1572962.
JD176036 - Sequence 157060 from Patent EP1572962.
JD431876 - Sequence 412900 from Patent EP1572962.
JD254674 - Sequence 235698 from Patent EP1572962.
MA869004 - JP 2018536436-A/840: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869005 - JP 2018536436-A/841: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869006 - JP 2018536436-A/842: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869007 - JP 2018536436-A/843: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869008 - JP 2018536436-A/844: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869009 - JP 2018536436-A/845: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869010 - JP 2018536436-A/846: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869011 - JP 2018536436-A/847: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869012 - JP 2018536436-A/848: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869013 - JP 2018536436-A/849: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869014 - JP 2018536436-A/850: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869015 - JP 2018536436-A/851: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869016 - JP 2018536436-A/852: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869017 - JP 2018536436-A/853: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869018 - JP 2018536436-A/854: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869033 - JP 2018536436-A/869: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869034 - JP 2018536436-A/870: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869035 - JP 2018536436-A/871: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869039 - JP 2018536436-A/875: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878205 - JP 2018536436-A/10041: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869040 - JP 2018536436-A/876: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878204 - JP 2018536436-A/10040: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869041 - JP 2018536436-A/877: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869042 - JP 2018536436-A/878: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869043 - JP 2018536436-A/879: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869044 - JP 2018536436-A/880: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869045 - JP 2018536436-A/881: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869049 - JP 2018536436-A/885: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869050 - JP 2018536436-A/886: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869051 - JP 2018536436-A/887: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878198 - JP 2018536436-A/10034: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869052 - JP 2018536436-A/888: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878196 - JP 2018536436-A/10032: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869063 - JP 2018536436-A/899: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869064 - JP 2018536436-A/900: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869065 - JP 2018536436-A/901: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869066 - JP 2018536436-A/902: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878200 - JP 2018536436-A/10036: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869067 - JP 2018536436-A/903: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878201 - JP 2018536436-A/10037: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869068 - JP 2018536436-A/904: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869069 - JP 2018536436-A/905: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA878197 - JP 2018536436-A/10033: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869070 - JP 2018536436-A/906: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869078 - JP 2018536436-A/914: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869079 - JP 2018536436-A/915: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869080 - JP 2018536436-A/916: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869081 - JP 2018536436-A/917: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869087 - JP 2018536436-A/923: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869088 - JP 2018536436-A/924: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869089 - JP 2018536436-A/925: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869090 - JP 2018536436-A/926: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869091 - JP 2018536436-A/927: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869092 - JP 2018536436-A/928: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869093 - JP 2018536436-A/929: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869104 - JP 2018536436-A/940: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869105 - JP 2018536436-A/941: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869106 - JP 2018536436-A/942: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869107 - JP 2018536436-A/943: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869108 - JP 2018536436-A/944: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869109 - JP 2018536436-A/945: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869110 - JP 2018536436-A/946: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869111 - JP 2018536436-A/947: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869112 - JP 2018536436-A/948: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869113 - JP 2018536436-A/949: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869114 - JP 2018536436-A/950: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MA869115 - JP 2018536436-A/951: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
MP231162 - Sequence 186 from Patent EP3512950.
LY600617 - KR 1020180133840-A/10779: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY600616 - KR 1020180133840-A/10778: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY600610 - KR 1020180133840-A/10772: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY600608 - KR 1020180133840-A/10770: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY600612 - KR 1020180133840-A/10774: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY600613 - KR 1020180133840-A/10775: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY600609 - KR 1020180133840-A/10771: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591416 - KR 1020180133840-A/840: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591417 - KR 1020180133840-A/841: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591418 - KR 1020180133840-A/842: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591419 - KR 1020180133840-A/843: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591420 - KR 1020180133840-A/844: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591421 - KR 1020180133840-A/845: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591422 - KR 1020180133840-A/846: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591423 - KR 1020180133840-A/847: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591424 - KR 1020180133840-A/848: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591425 - KR 1020180133840-A/849: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591426 - KR 1020180133840-A/850: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591427 - KR 1020180133840-A/851: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591428 - KR 1020180133840-A/852: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591429 - KR 1020180133840-A/853: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591430 - KR 1020180133840-A/854: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591445 - KR 1020180133840-A/869: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591446 - KR 1020180133840-A/870: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591447 - KR 1020180133840-A/871: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591451 - KR 1020180133840-A/875: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591452 - KR 1020180133840-A/876: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591453 - KR 1020180133840-A/877: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591454 - KR 1020180133840-A/878: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591455 - KR 1020180133840-A/879: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591456 - KR 1020180133840-A/880: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591457 - KR 1020180133840-A/881: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591461 - KR 1020180133840-A/885: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591462 - KR 1020180133840-A/886: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591463 - KR 1020180133840-A/887: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591464 - KR 1020180133840-A/888: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591475 - KR 1020180133840-A/899: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591476 - KR 1020180133840-A/900: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591477 - KR 1020180133840-A/901: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591478 - KR 1020180133840-A/902: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591479 - KR 1020180133840-A/903: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591480 - KR 1020180133840-A/904: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591481 - KR 1020180133840-A/905: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591482 - KR 1020180133840-A/906: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591490 - KR 1020180133840-A/914: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591491 - KR 1020180133840-A/915: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591492 - KR 1020180133840-A/916: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591493 - KR 1020180133840-A/917: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591499 - KR 1020180133840-A/923: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591500 - KR 1020180133840-A/924: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591501 - KR 1020180133840-A/925: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591502 - KR 1020180133840-A/926: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591503 - KR 1020180133840-A/927: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591504 - KR 1020180133840-A/928: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591505 - KR 1020180133840-A/929: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591516 - KR 1020180133840-A/940: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591517 - KR 1020180133840-A/941: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591518 - KR 1020180133840-A/942: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591519 - KR 1020180133840-A/943: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591520 - KR 1020180133840-A/944: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591521 - KR 1020180133840-A/945: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591522 - KR 1020180133840-A/946: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591523 - KR 1020180133840-A/947: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591524 - KR 1020180133840-A/948: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591525 - KR 1020180133840-A/949: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591526 - KR 1020180133840-A/950: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.
LY591527 - KR 1020180133840-A/951: COMPOSITIONS AND METHODS FOR IMMUNOONCOLOGY.

-  Biochemical and Signaling Pathways
  BioCarta from NCI Cancer Genome Anatomy Project
h_tcrPathway - T Cell Receptor Signaling Pathway
h_tob1Pathway - Role of Tob in T-cell activation
h_thelperPathway - T Helper Cell Surface Molecules
h_CSKPathway - Activation of Csk by cAMP-dependent Protein Kinase Inhibits Signaling through the T Cell Receptor
h_ctla4Pathway - The Co-Stimulatory Signal During T-cell Activation
h_ctlPathway - CTL mediated immune response against target cells
h_tcytotoxicPathway - T Cytotoxic Cell Surface Molecules
h_tcraPathway - Lck and Fyn tyrosine kinases in initiation of TCR Activation
h_tcapoptosisPathway - HIV Induced T Cell Apoptosis
h_stathminPathway - Stathmin and breast cancer resistance to antimicrotubule agents
h_IL12Pathway - IL12 and Stat4 Dependent Signaling Pathway in Th1 Development
h_no2il12Pathway - NO2-dependent IL 12 Pathway in NK cells
h_il17Pathway - IL 17 Signaling Pathway
h_tcrmolecule - T Cell Receptor and CD3 Complex

Reactome (by CSHL, EBI, and GO)

Protein P09693 (Reactome details) participates in the following event(s):

R-HSA-8850326 TCR binds self-lipid-based antigen via CD1
R-HSA-8850356 TCR binds microbial lipid-based antigen via CD1
R-HSA-2029455 Cross-linking of FCGRIA with IgG-coated Ag
R-HSA-8866277 AP-2 directly binds some endocytic cargo
R-HSA-198955 TCR complex interacts with peptide antigen-presenting MHC Class I
R-HSA-202214 Dephosphorylation of Lck-pY505 by CD45
R-HSA-202233 Inactivation of Lck by Csk
R-HSA-202291 Activation of Lck
R-HSA-8852200 Inactivation of LCK by PTPN22
R-HSA-202165 Phosphorylation of ITAM motifs in CD3 complexes
R-HSA-2029457 Cross-linking of FCGRIIIA with IgG-coated Ag
R-HSA-202344 Recruitment of ZAP-70 to phosphorylated ITAMs
R-HSA-389758 Dephosphorylation of CD3-zeta by PD-1 bound phosphatases
R-HSA-202168 Phosphorylation of ZAP-70 by Lck
R-HSA-202307 Change of PKC theta conformation
R-HSA-8867756 CLASP proteins and cargo are recruited to the nascent clathrin-coated pit
R-HSA-202174 Activation of ZAP-70
R-HSA-8855381 PTPN22 dephosphorylates ZAP70
R-HSA-2029452 Recruitment of SYK to phosphorylated ITAMs
R-HSA-8868071 Clathrin recruits PIK3C2A
R-HSA-8868661 Dynamin-mediated GTP hydrolysis promotes vesicle scission
R-HSA-8868648 SYNJ hydrolyze PI(4,5)P2 to PI(4)P
R-HSA-202216 Phosphorylation of SLP-76
R-HSA-202245 Phosphorylation of TBSMs in LAT
R-HSA-2029449 Phosphorylation of SYK by Src kinases
R-HSA-2029270 Recruitment of PLCgamma to membrane
R-HSA-2029273 PI3K binds to p-6Y-SYK
R-HSA-2029458 Recruitment of VAV1 to p-6Y-SYK
R-HSA-2197697 Recruitment of CRKII:DOCK180:ELMO complex to FCGR
R-HSA-2029272 Release of PLCG from FCGR
R-HSA-8871194 RAB5 and GAPVD1 bind AP-2
R-HSA-8868658 HSPA8-mediated ATP hydrolysis promotes vesicle uncoating
R-HSA-8868659 Clathrin recruits auxilins to the clathrin-coated vesicle
R-HSA-8868660 Auxilin recruits HSPA8:ATP to the clathrin-coated vesicle
R-HSA-8867754 F- and N- BAR domain proteins bind the clathrin-coated pit
R-HSA-8868230 SNX9 recruits components of the actin polymerizing machinery
R-HSA-202248 Phosphorylation of PLC-gamma1
R-HSA-2029453 Phosphorylation of VAV
R-HSA-2029268 Phosphorylation and activation of PLCG
R-HSA-8868072 Clathrin-associated PIK3C2A phosphorylates PI(4)P to PI(3,4)P2
R-HSA-8868236 BAR domain proteins recruit dynamin
R-HSA-2029467 Activation of RAC1 by CRKII:DOCK180:ELMO
R-HSA-2029451 Activation of RAC1 by VAV
R-HSA-2029271 PI3K phosphorylates PIP2 to PIP3
R-HSA-8868651 Endophilins recruit synaptojanins to the clathrin-coated pit
R-HSA-198933 Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell
R-HSA-2029481 FCGR activation
R-HSA-8856825 Cargo recognition for clathrin-mediated endocytosis
R-HSA-202427 Phosphorylation of CD3 and TCR zeta chains
R-HSA-1280218 Adaptive Immune System
R-HSA-2029480 Fcgamma receptor (FCGR) dependent phagocytosis
R-HSA-8856828 Clathrin-mediated endocytosis
R-HSA-202430 Translocation of ZAP-70 to Immunological synapse
R-HSA-389948 PD-1 signaling
R-HSA-202403 TCR signaling
R-HSA-202424 Downstream TCR signaling
R-HSA-168256 Immune System
R-HSA-168249 Innate Immune System
R-HSA-199991 Membrane Trafficking
R-HSA-388841 Costimulation by the CD28 family
R-HSA-2029482 Regulation of actin dynamics for phagocytic cup formation
R-HSA-5653656 Vesicle-mediated transport
R-HSA-202433 Generation of second messenger molecules
R-HSA-2029485 Role of phospholipids in phagocytosis

-  Other Names for This Gene
  Alternate Gene Symbols: CD3G_HUMAN, ENST00000532917.1, ENST00000532917.2, NM_000073, P09693, Q2HIZ6, T3G, uc324kty.1, uc324kty.2
UCSC ID: ENST00000532917.3_6
RefSeq Accession: NM_000073.3
Protein: P09693 (aka CD3G_HUMAN)

-  Gene Model Information
  Click here for a detailed description of the fields of the table above.

-  Methods, Credits, and Use Restrictions
  Click here for details on how this gene model was made and data restrictions if any.